{"entity":{"type":"insider","cik":"0001557657","url":"/insider/0001557657","json_url":"/insider/0001557657.json","name":"Schwabe Stefan K.F.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":9,"first":"2015-06-12","last":"2020-12-22","span_basis":"filed_date"},"name_variants":[{"name":"Schwabe Stefan K.F.","source":"filing","n_filings":9,"first_seen":"2015-06-12","last_seen":"2020-12-22"}],"transactions":[{"id":3177159,"accession":"0001104659-20-138671","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-138671","line_url":"/filing/0001104659-20-138671#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001557657","owner_name":"Schwabe Stefan K.F.","owner_url":"/insider/0001557657","role":"Officer (Executive Vice President & CMO)","officer_title":"Executive Vice President & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46347.0,"shares_display":"46,347","price_per_share":22.1042,"price_display":"22.10","price_state":"stated","total_value":1024463.3574,"total_display":"1,024,463.36","shares_owned_after":2772.0,"shares_owned_after_display":"2,772","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-21","filed_date":"2020-12-22","scope":"insider"},{"id":2968965,"accession":"0001104659-20-135882","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-20-135882","line_url":"/filing/0001104659-20-135882#line-4","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001557657","owner_name":"Schwabe Stefan K.F.","owner_url":"/insider/0001557657","role":"Officer (Executive Vice President & CMO)","officer_title":"Executive Vice President & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":21.8579,"price_display":"21.86","price_state":"stated","total_value":1092895.0,"total_display":"1,092,895.00","shares_owned_after":6425.0,"shares_owned_after_display":"6,425","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-14","filed_date":"2020-12-15","scope":"insider"},{"id":2968961,"accession":"0001104659-20-135882","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-20-135882","line_url":"/filing/0001104659-20-135882#line-3","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001557657","owner_name":"Schwabe Stefan K.F.","owner_url":"/insider/0001557657","role":"Officer (Executive Vice President & CMO)","officer_title":"Executive Vice President & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3653.0,"shares_display":"3,653","price_per_share":22.0007,"price_display":"22.00","price_state":"stated","total_value":80368.5571,"total_display":"80,368.56","shares_owned_after":2772.0,"shares_owned_after_display":"2,772","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-14","filed_date":"2020-12-15","scope":"insider"},{"id":6621920,"accession":"0001104659-18-041086","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-18-041086","line_url":"/filing/0001104659-18-041086#line-3","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS INC","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001557657","owner_name":"Schwabe Stefan K.F.","owner_url":"/insider/0001557657","role":"Officer (Executive VP R&D, CMO)","officer_title":"Executive VP R&D, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":54.3892,"price_display":"54.39","price_state":"stated","total_value":3263352.0,"total_display":"3,263,352.00","shares_owned_after":1967.0,"shares_owned_after_display":"1,967","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-18","filed_date":"2018-06-19","scope":"insider"},{"id":4183926,"accession":"0001104659-17-056610","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-17-056610","line_url":"/filing/0001104659-17-056610#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS INC","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001557657","owner_name":"Schwabe Stefan K.F.","owner_url":"/insider/0001557657","role":"Officer (Executive Vice President R&D)","officer_title":"Executive Vice President R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":95000.0,"shares_display":"95,000","price_per_share":46.585,"price_display":"46.58","price_state":"stated","total_value":4425575.0,"total_display":"4,425,575.00","shares_owned_after":1855.0,"shares_owned_after_display":"1,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-07","filed_date":"2017-09-11","scope":"insider"},{"id":8743607,"accession":"0001104659-15-054456","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-15-054456","line_url":"/filing/0001104659-15-054456#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS INC","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001557657","owner_name":"Schwabe Stefan K.F.","owner_url":"/insider/0001557657","role":"Officer (Executive Vice President R&D)","officer_title":"Executive Vice President R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1700.0,"shares_display":"1,700","price_per_share":21.2,"price_display":"21.20","price_state":"stated","total_value":36040.0,"total_display":"36,040.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-28","filed_date":"2015-07-29","scope":"insider"},{"id":8743603,"accession":"0001104659-15-054456","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-054456","line_url":"/filing/0001104659-15-054456#line-1","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS INC","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001557657","owner_name":"Schwabe Stefan K.F.","owner_url":"/insider/0001557657","role":"Officer (Executive Vice President R&D)","officer_title":"Executive Vice President R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":650.0,"shares_display":"650","price_per_share":21.21,"price_display":"21.21","price_state":"stated","total_value":13786.5,"total_display":"13,786.50","shares_owned_after":1700.0,"shares_owned_after_display":"1,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-28","filed_date":"2015-07-29","scope":"insider"},{"id":9223313,"accession":"0001104659-15-054453","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-054453","line_url":"/filing/0001104659-15-054453#line-1","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS INC","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001557657","owner_name":"Schwabe Stefan K.F.","owner_url":"/insider/0001557657","role":"Officer (Executive Vice President R&D)","officer_title":"Executive Vice President R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1950.0,"shares_display":"1,950","price_per_share":19.23,"price_display":"19.23","price_state":"stated","total_value":37498.5,"total_display":"37,498.50","shares_owned_after":2350.0,"shares_owned_after_display":"2,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-13","filed_date":"2015-07-29","scope":"insider"},{"id":8395308,"accession":"0001104659-15-050965","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-050965","line_url":"/filing/0001104659-15-050965#line-1","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS INC","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001557657","owner_name":"Schwabe Stefan K.F.","owner_url":"/insider/0001557657","role":"Officer (Executive Vice President R&D)","officer_title":"Executive Vice President R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1950.0,"shares_display":"1,950","price_per_share":19.23,"price_display":"19.23","price_state":"stated","total_value":37498.5,"total_display":"37,498.50","shares_owned_after":844.0,"shares_owned_after_display":"844","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-13","filed_date":"2015-07-14","scope":"insider"},{"id":8357105,"accession":"0001104659-15-045405","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-045405","line_url":"/filing/0001104659-15-045405#line-1","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS INC","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001557657","owner_name":"Schwabe Stefan K.F.","owner_url":"/insider/0001557657","role":"Officer (Executive Vice President R&D)","officer_title":"Executive Vice President R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2051.0,"shares_display":"2,051","price_per_share":18.27,"price_display":"18.27","price_state":"stated","total_value":37471.77,"total_display":"37,471.77","shares_owned_after":2794.0,"shares_owned_after_display":"2,794","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-12","filed_date":"2015-06-15","scope":"insider"},{"id":8596200,"accession":"0001104659-15-045137","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-15-045137","line_url":"/filing/0001104659-15-045137#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS INC","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001557657","owner_name":"Schwabe Stefan K.F.","owner_url":"/insider/0001557657","role":"Officer (Executive Vice President R&D)","officer_title":"Executive Vice President R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2286.0,"shares_display":"2,286","price_per_share":16.435,"price_display":"16.44","price_state":"stated","total_value":37570.41,"total_display":"37,570.41","shares_owned_after":4845.0,"shares_owned_after_display":"4,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-11","filed_date":"2015-06-12","scope":"insider"},{"id":8596197,"accession":"0001104659-15-045137","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-045137","line_url":"/filing/0001104659-15-045137#line-1","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS INC","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001557657","owner_name":"Schwabe Stefan K.F.","owner_url":"/insider/0001557657","role":"Officer (Executive Vice President R&D)","officer_title":"Executive Vice President R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1345.0,"shares_display":"1,345","price_per_share":16.32,"price_display":"16.32","price_state":"stated","total_value":21950.4,"total_display":"21,950.40","shares_owned_after":7131.0,"shares_owned_after_display":"7,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-11","filed_date":"2015-06-12","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001356576","name":"SUPERNUS PHARMACEUTICALS, INC.","url":"/issuer/0001356576","role":"Officer (Executive Vice President & CMO)","n_filings":9,"first_seen":"2015-06-12","last_seen":"2020-12-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001557657","retrieved_at":"2026-08-22T01:59:35+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}